Back to today’s briefing

Story perspectives

Allogeneic Cell Therapy Market to Hit $18.5 Billion by 2030

1/21/2025

25 3

Summary

Story summary

The allogeneic cell therapy market is set to soar to USD 18.5 billion by 2030, fueled by a remarkable 17.8% growth rate. This surge is driven by the increasing prevalence of chronic diseases, innovative manufacturing techniques, and supportive regulations. Countries like Vietnam, Thailand, Japan, and South Korea are actively collaborating and launching initiatives, unlocking exciting growth potential in this transformative field.

History

Historical Context

The rise of allogeneic cell therapy mirrors past innovations in medical treatments, like the first successful bone marrow transplant in 1968. As chronic diseases increase, advancements in cell therapy reflect a historical trend of leveraging technology to address healthcare challenges, paving the way for significant market growth by 2030.

1 of 2

Story summary

The allogeneic cell therapy market is set to soar to USD 18.5 billion by 2030, fueled by a remarkable 17.8% growth rate. This surge is driven by the increasing prevalence of chronic diseases, innovative manufacturing techniques, and supportive regulations. Countries like Vietnam, Thailand, Japan, and South Korea are actively collaborating and launching initiatives, unlocking exciting growth potential in this transformative field.

1 / 2